https://i.imgur.com/6A3qYIa.pngAfter a long last, pharmaceutical companies will be able to track sales.
Keeping a medical record in a safe blockchain application will allow the doctor to quickly see the patient's history, regardless of whether he was previously examined by this specialist or not.
Thanks to the technologies, working principle of pharmaceutical companies will change. Part of the work, which is currently performed by medical representatives will be carried out by the ecosystem.
Thus, their main tasks will be to build trust relationships between the doctor and the company (to acquaint the doctor with the company, its products, invite to conferences / medical meetings,
offer to conduct product research and publish their professional opinion about this experience ).
For those publications, doctors will be able to receive rewards such as bonuses, and a certain percentage of the rating. For pharmaceutical companies, reviews will be
one of the indicators of a drug rating, based on which the volumes of demand / sales will vary.
When people search for information on the Internet, they often use Wikipedia as a trusted resource. The international medical ecosystem will let everyone
expressed their concerns to doctors immediately.
The doctor is a very important profession, they put other people's lives at the heart of their own lives. The ratio between total number
of doctors and patients is 1.5:1000 people. And in some countries this coefficient varies from 0.02 to 5. Doctors have unique and irreplaceable
knowledge that enables them to save thousands of lives each day.
Communication between medical representatives and physicians should be held systematically, scheduled and in free from admission of patients time.
Situations that require consultation, but do not require physical presence, can also be solved online. Each doctor will have an assistant, represented by
artificial intelligence, which can react instantly without distracting the specialist from current tasks (carrying out those admissions that require physical presence).
Thus, the efficiency of doctors will increase dramatically.
The patient finds a doctor, and sends an appeal to him. The doctor responds to the appeal. If the question requires an online consultation and this need
can be solved without the doctor – artificial intelligence takes care of it.
If the question requires a participation of a specialist - this occurs during hours of online consultation with a doctor. When a question requires a physical examination,
an appointment is being set. The Medical Ecosystem changes the way some doctors work. They can set their schedules for themselves to work out the necessary hours,
and at the same time act according to the situation. Efficiency lies in structuring the needs and methods of satisfying them. Patients will be able to receive a response to
their request almost instantly, thereby saving time on the road and waiting.
When it comes to surgery or any complicated, not an everyday, decision (related to health) to be made by the patient, he/she needs to discover about the doctor, how many
patients the specialist consulted, how many people he cured, and what is the doctor’s overall rating . Gratitude to the doctor who decides the vital issues can not be expressed in money.
This can only be done through comments, describing your particular case (the patient's anonymity can be preserved).
Electronic prescriptions will allow you to integrate all the necessary data (patient's card, doctor's seal and other template fields necessary to fill in),
and the doctor (in the absence of the AI assistant) only needs to specify the dosage of the needed active ingredients, schedule and the duration of their intake until the next examination.
This concludes the physician's physical participation. The Medical Ecosystem itself offers to the patient all the available drugs in the region that correspond
to the dosages of the active substances needed. As we have mentioned, one of the indicators of the rating of a drug or other medical product will be the research.
These studies will be conducted in laboratories and clinics.
Patients who decide to participate in the use of new drugs will be able to write comments about their health. Doctors observing such patients will also leave a comment.
Together, this will form a comprehensive review, which will create a history of the drug, based on exclusively by practical cases. This is the marketing of the drug.
Choosing the right drugs, the patient makes an order. Thus, it will be possible to trace the complete history of all consumers.
Pharmaceutical companies and their distributors will know their customers directly through their personal cabinet and purchase history.
These data will enable them to build the right loyalty system.
These data will enable them to build the right loyalty system. Pharmaceutical companies will work on the production of quality products,
because low-quality products will simply not be sold, and quality ones will not require a large share of the marketing budget
(thereby reducing the cost of the drug and making it more affordable or producing more drugs, donating part of them to the funds of free medical insurance).
This will contribute to the reduction of stress and time, will increase the amount of services provided in the field of medicine without an artificial increase of specialists in this field.
